Team

• Patient Reported Outcomes
• Translation and Linguistic Validation
• Health Economics
• Epidemiology

Translation and Linguistic Validation Team

Oxford Outcomes has been active in the field of Translation and Linguistic Validation of patient reported outcome (PRO) instruments and medical information for over a decade, making us one of the most experienced service providers in this field. Oxford Outcomes have Translation & Linguistic Validation teams in Oxford, UK and Raleigh, USA. The team is led by:

• Diane Wild, Vice President, Translation Services
• Gareth Ellis, Director, Translation Services (Oxford)
• Brittany Bodart, Director, Translation Services (Raleigh)

Our management team are key contributors to international discussion of scientific methods, best practice guidance and regulation. Diane Wild led the ISPOR Task Force on Translation and Linguistic Validation, which in turn has been influential in the development of FDA guidance. In addition Gareth Ellis is contributing to the development of a new translation quality standard, ISO17100.

Our in-house team of project managers combines expertise in translation processes and quality control with in-depth understanding of PRO research, clinical trial design and the regulatory environment. Their connections within Oxford Outcomes, with the PRO and Health Economics teams, put them in a strong position to make the important translation and equivalency decisions that the translation and linguistic process requires. In addition their careful and rigorous management of translator, clinician, editor and proof-reader inputs maintains the very highest standards for our work.

With the inputs of our in-house PRO, Health Economics, and Epidemiology teams - as well as our clinical networks within ICON Clinical Research - we ensure that sometimes complex quality of life (QoL), treatment satisfaction, econometric and other “health value” concepts are being accurately and effectively translated.